Piedmont Investment Advisors LLC decreased its position in HealthSouth Corp (NYSE:HLS) by 30.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,338 shares of the company’s stock after selling 14,488 shares during the quarter. Piedmont Investment Advisors LLC’s holdings in HealthSouth were worth $1,545,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in HLS. Teacher Retirement System of Texas boosted its holdings in shares of HealthSouth by 0.7% in the 2nd quarter. Teacher Retirement System of Texas now owns 7,117 shares of the company’s stock worth $344,000 after purchasing an additional 48 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of HealthSouth by 0.5% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,072 shares of the company’s stock worth $633,000 after purchasing an additional 64 shares during the period. NGAM Advisors L.P. boosted its holdings in shares of HealthSouth by 1.4% in the 2nd quarter. NGAM Advisors L.P. now owns 10,448 shares of the company’s stock worth $506,000 after purchasing an additional 142 shares during the period. Renaissance Group LLC boosted its holdings in shares of HealthSouth by 1.9% in the 2nd quarter. Renaissance Group LLC now owns 8,288 shares of the company’s stock worth $401,000 after purchasing an additional 152 shares during the period. Finally, Symphony Asset Management LLC boosted its holdings in shares of HealthSouth by 4.4% in the 2nd quarter. Symphony Asset Management LLC now owns 6,228 shares of the company’s stock worth $301,000 after purchasing an additional 261 shares during the period. 93.37% of the stock is currently owned by institutional investors and hedge funds.
In other HealthSouth news, Director Yvonne M. Curl acquired 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The stock was bought at an average price of $45.95 per share, for a total transaction of $45,950.00. Following the acquisition, the director now directly owns 64,144 shares in the company, valued at $2,947,416.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by insiders.
HealthSouth Corp (HLS) opened at $50.10 on Friday. HealthSouth Corp has a 1-year low of $38.24 and a 1-year high of $50.41. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. The stock has a market capitalization of $4,856.55, a price-to-earnings ratio of 17.71, a P/E/G ratio of 1.82 and a beta of 0.54.
HealthSouth (NYSE:HLS) last posted its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The company had revenue of $995.60 million during the quarter, compared to analysts’ expectations of $985.75 million. During the same quarter in the previous year, the business earned $0.65 EPS. HealthSouth’s revenue was up 7.4% compared to the same quarter last year. equities analysts expect that HealthSouth Corp will post 2.72 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Friday, December 29th. HealthSouth’s payout ratio is currently 36.36%.
A number of brokerages have recently commented on HLS. Robert W. Baird reiterated a “buy” rating and issued a $55.00 target price on shares of HealthSouth in a report on Monday, October 9th. Zacks Investment Research upgraded HealthSouth from a “hold” rating to a “buy” rating and set a $52.00 target price for the company in a report on Monday, October 30th. William Blair reiterated an “outperform” rating on shares of HealthSouth in a report on Tuesday, November 21st. KeyCorp reiterated a “hold” rating on shares of HealthSouth in a report on Thursday, September 7th. Finally, Royal Bank of Canada reiterated a “buy” rating and issued a $55.00 target price on shares of HealthSouth in a report on Wednesday, September 6th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $51.75.
TRADEMARK VIOLATION WARNING: “Piedmont Investment Advisors LLC Trims Holdings in HealthSouth Corp (HLS)” was first reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.truebluetribune.com/2017/12/16/piedmont-investment-advisors-llc-trims-holdings-in-healthsouth-corp-hls.html.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).
Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.